T7 RNA polymerase-independent expression of reporter genes from a T7 promoter-driven SARS-CoV-2 replicon-encoding DNA in human cells
Ronja FriedhoffiD, Ghada Elfayres, Natacha MérindoliD, Isabel Desgagné‐PenixiD, Lionel BerthouxiD
Abstract
Replicons, derived from RNA viruses, are genetic constructs retaining essential viral enzyme genes while lacking key structural protein genes. Upon introduction into cells, the genes carried by the replicon RNA are expressed, and the RNA self-replicates, yet viral particle production does not take place. Typically, RNA replicons are transcribed in vitro and are then electroporated in cells. However, it would be advantageous for the replicon to be generated in cells following DNA transfection instead of RNA. In this study, a bacterial artificial chromosome (BAC) DNA encoding a SARS-CoV-2 replicon under control of a T7 promoter was transfected into HEK293T cells engineered to functionally express the T7 RNA polymerase (T7 RNAP). Upon transfection of the BAC DNA, we observed low, but reproducible expression of reporter proteins GFP and luciferase carried by this replicon. Expression of the reporter proteins required linearization of the BAC DNA prior to transfection. Surprisingly, however, expression occurred independently of T7 RNAP. Gene expression was also insensitive to remdesivir treatment, suggesting that it did not involve self-replication of replicon RNA. Similar results were obtained in highly SARS-CoV-2 infection-permissive Calu-3 cells. Strikingly, prior expression of the SARS-CoV-2 N protein boosted expression from transfected SARS-CoV-2 RNA replicon but not from the replicon BAC DNA. In conclusion, transfection of a large DNA encoding a coronaviral replicon led to reproducible replicon gene expression through an unidentified mechanism. These findings highlight a novel pathway toward replicon gene expression from transfected replicon cDNA, offering valuable insights for the development of methods for DNA-based RNA replicon applications.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- FWCI
- 0.30
- Field percentile
- 48th percentile
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A bacterial artificial chromosome (BAC)-vectored noninfectious replicon of SARS-CoV-2
- A PCR amplicon-based SARS-CoV-2 replicon for antiviral screening
T. Kotaki, X. Xie, … M. Kameoka·bioRxiv·Aug 28, 2020
- Establishment of a stable SARS-CoV-2 replicon system for application in high-throughput screening.
T. Tanaka, A. Saito, … K. Moriishi·bioRxiv·Dec 23, 2021
- Development of SARS-CoV-2 replicons for the ancestral virus and variant of concern Delta for antiviral screening.
M. Erdmann, M. Kavanagh Williamson, … A. D. Davidson·bioRxiv·Oct 11, 2022
- Construction of Fosmid-based SARS-CoV-2 replicons for antiviral drug screening and replication analyses in biosafety level 2 facilities
S. Takazawa, T. Kotaki, … M. Kameoka·bioRxiv·Feb 15, 2023
- Subgenomic SARS-CoV-2 replicon and reporter replicon cell lines enable ultrahigh throughput antiviral screening and mechanistic studies with antivirals, viral mutations or host factors that affect COVID-19 replication
S. Lan, P. R. Tedbury, … S. G. Sarafianos·bioRxiv·Dec 29, 2021